Clinical Trial Update: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence [NA]

View source ↗

Summary

The University of Rochester's study evaluating focal salvage high-dose-rate brachytherapy for prostate gland recurrence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Rochester | Conditions: Prostate Cancer, HDR | NA | Status: WITHDRAWN